PillRx only · Tablet, Film Coated · Oral
Olmesartan Medoxomil And Amlodipine Besylate And Hydrochlorothiazide
Amlodipine Besylate + Hydrochlorothiazide + Olmesartan Medoxomil
1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US5 NDCs
1 active makers
1 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 5 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$1.031
Latest avg · Jul 22, 2026
-16%
Since Feb 4, 2026
1
Active US suppliers
100%
Top-2 supplier share*
Medicaid dispensing volume
No Medicaid utilization on record for this drug concept yet. Quarterly volume (CMS State Drug Utilization Data) loads with the utilization ETL.
Who makes it1 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Slate Run Pharmaceuticals, LLC | unknown | 10 | SUPPLYING |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.